Dun Yang – President & CEO, Anticancer Bioscience
Anticancer Bioscience is an exciting international precision oncology company, applying synthetic lethal approaches to develop targeted cancer…
Tagged with Medicine
Sizhen Wang – CEO & Co-Founder, Genetron Health
Genetron Health is a publicly-traded China-based precision oncology company, covering the “full-cycle” of cancer care, from early screening,…
Miro Venturi – CEO, Sintetica
Dr Miro Venturi of Swiss injectable anaesthetics and analgesics specialist Sintetica outlines his career journey, why personalised medicine is about…
Saudi Arabia: SFDA CEO Sets Out Strategic Priorities
In a recent conversation with PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey, CEO of the Saudi Food and Drug Authority (SFDA) outlined the…
Hisham Bin Saad Al-Jadhey – CEO, Saudi Food and Drug…
Speaking exclusively to PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey, CEO of the Saudi Food and Drug Authority (SFDA), outlines the SFDA's key…
Gideon Ho – Co-Founder & CEO, HistoIndex
Dr Gideon Ho, co-founder and CEO of HistoIndex, shares the story of the company’s establishment in 2010, their proprietary technology to provide the…
Can Sweden take the lead in Precision Medicine?
Anders Blanck of Lif, the trade association for the research-based Swedish pharmaceutical industry, outlines the steps already being put in place for…
2020’s Top 7 Biotech IPOs in Profile
Following the recent news of Remegen's massive USD 515 million IPO in November 2020, we bring you profiles of the seven biggest biotech companies to…
China: Hitgen Aims to Strengthen its “Innovation Foundation”…
PharmaBoardroom had the pleasure of interviewing HitGen chairman & CEO Dr Jin LI in July regarding the company’s focus on DNA-encoded chemical…
Chinese Biotech Strategies: The Pros & Cons of In-Licensing
Since the Chinese biopharma boom started in the late-2000s, Chinese biotechs have seen in-licensing as a shortcut to establishing their own portfolios…
Ken-ichiro Hata – Representative Director &…
Dr Ken-ichiro Hata, representative director and chairperson of Japan's Forum for Innovative Regenerative Medicine (FIRM) outlines the organisation's…
Kerry Blanchard – CEO, Everest Medicines, China
Dr Kerry Blanchard explains why he took on the challenge of becoming CEO of Chinese biotech Everest Medicines and how Everest’s internationalist…
